Drug Shortage Report for APO-ABACAVIR-LAMIVUDINE
Report ID | 82102 |
Drug Identification Number | 02399539 |
Brand name | APO-ABACAVIR-LAMIVUDINE |
Common or Proper name | ABACAVIR-LAMIVUDINE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | ABACAVIR LAMIVUDINE |
Strength(s) | 600MG 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BLS |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-04-17 |
Estimated end date | 2019-08-09 |
Actual end date | 2019-07-26 |
Shortage status | Resolved |
Updated date | 2019-07-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-07-29 | French | Compare |
v7 | 2019-07-29 | English | Compare |
v6 | 2019-07-12 | French | Compare |
v5 | 2019-07-12 | English | Compare |
v4 | 2019-06-21 | French | Compare |
v3 | 2019-06-21 | English | Compare |
v2 | 2019-04-22 | French | Compare |
v1 | 2019-04-22 | English | Compare |
Showing 1 to 8 of 8